11,726 Shares in Acadia Healthcare Company, Inc. $ACHC Purchased by Aristeia Capital L.L.C.

Key Points

• Aristeia Capital L.L.C. invested approximately $356,000 in Acadia Healthcare Company, acquiring 11,726 shares during the first quarter of this year.
• Several institutional investors, including Goldman Sachs and Silver Rock Financial, have significantly increased their stakes in Acadia Healthcare in recent months.
• Acadia Healthcare reported earnings of $0.83 per share for the last quarter, surpassing estimates, with a revenue of $869.23 million, marking a 9.2% year-over-year increase.

Aristeia Capital L.L.C. purchased a new stake in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report) during the first quarter, according to the company in its most recent disclosure with the SEC. The firm purchased 11,726 shares of the company's stock, valued at approximately $356,000.

A number of other institutional investors have also recently made changes to their positions in the stock. UMB Bank n.a. boosted its holdings in shares of Acadia Healthcare by 149.5% in the first quarter. UMB Bank n.a. now owns 1,260 shares of the company's stock worth $38,000 after buying an additional 755 shares during the last quarter. Caitong International Asset Management Co. Ltd boosted its holdings in shares of Acadia Healthcare by 11,218.2% in the first quarter. Caitong International Asset Management Co. Ltd now owns 1,245 shares of the company's stock worth $38,000 after buying an additional 1,234 shares during the last quarter. State of Wyoming purchased a new position in shares of Acadia Healthcare in the fourth quarter worth approximately $56,000. Covestor Ltd boosted its holdings in shares of Acadia Healthcare by 56.0% in the first quarter. Covestor Ltd now owns 2,262 shares of the company's stock worth $69,000 after buying an additional 812 shares during the last quarter. Finally, Twin Tree Management LP boosted its holdings in shares of Acadia Healthcare by 185.8% in the first quarter. Twin Tree Management LP now owns 5,691 shares of the company's stock worth $173,000 after buying an additional 3,700 shares during the last quarter.

Wall Street Analyst Weigh In

ACHC has been the topic of a number of research reports. Stephens raised shares of Acadia Healthcare to a "hold" rating in a report on Monday, June 2nd. Barclays lowered their price target on shares of Acadia Healthcare from $28.00 to $20.00 and set an "equal weight" rating on the stock in a report on Thursday, August 7th. UBS Group reduced their price objective on shares of Acadia Healthcare from $45.00 to $31.00 and set a "buy" rating on the stock in a research report on Thursday, August 7th. Bank of America cut shares of Acadia Healthcare from a "buy" rating to a "neutral" rating and reduced their price objective for the company from $27.00 to $25.00 in a research report on Wednesday. Finally, Raymond James Financial reiterated an "outperform" rating and set a $26.00 price objective (down previously from $40.00) on shares of Acadia Healthcare in a research report on Thursday, August 14th. Eight analysts have rated the stock with a Buy rating and five have given a Hold rating to the company's stock. According to data from MarketBeat, Acadia Healthcare currently has an average rating of "Moderate Buy" and an average price target of $39.00.

Acadia Healthcare Trading Down 2.6%

NASDAQ ACHC traded down $0.58 on Friday, hitting $21.73. 2,150,271 shares of the stock were exchanged, compared to its average volume of 2,287,824. The company has a debt-to-equity ratio of 0.73, a quick ratio of 1.32 and a current ratio of 1.32. The stock has a fifty day moving average price of $22.09 and a two-hundred day moving average price of $24.29. The firm has a market capitalization of $2.01 billion, a P/E ratio of 14.39, a P/E/G ratio of 4.39 and a beta of 0.89. Acadia Healthcare Company, Inc. has a 52-week low of $17.13 and a 52-week high of $79.82.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last posted its quarterly earnings data on Tuesday, August 5th. The company reported $0.83 EPS for the quarter, topping the consensus estimate of $0.71 by $0.12. The company had revenue of $869.23 million during the quarter, compared to analyst estimates of $839.59 million. Acadia Healthcare had a net margin of 4.31% and a return on equity of 8.34%. Acadia Healthcare's quarterly revenue was up 9.2% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.91 earnings per share. Acadia Healthcare has set its FY 2025 guidance at 2.450-2.65 EPS. Research analysts forecast that Acadia Healthcare Company, Inc. will post 3.38 EPS for the current fiscal year.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.